Full Text View
Tabular View
Study Results
Related Studies
A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma
This study has been completed.
Study NCT00111007   Information provided by Bayer

First Received on May 16, 2005.   Last Updated on October 23, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial